Format

Send to

Choose Destination
Br J Obstet Gynaecol. 1996 Feb;103(2):150-3.

GnRH analogue in assessing chronic pelvic pain in women with residual ovaries.

Author information

1
Department of Obstetrics and Gynaecology, Kent and Canterbury Hospital, United Kingdom.

Abstract

OBJECTIVE:

To assess whether suppression of ovarian function by a gonadotrophin releasing hormone (GnRH) analogue could assist in the diagnosis of chronic pelvic pain in women with residual ovaries.

DESIGN:

Uncontrolled, observational study.

SETTING:

District general hospital (seven women) and teaching hospital (one woman).

SETTING:

Eight women with residual ovaries and chronic pelvic pain.

INTERVENTIONS:

Goserelin 3.6 mg every 28 days was used followed by surgery to remove residual ovaries.

MAIN OUTCOME MEASURES:

The women's response to goserelin and surgery (12 months or more post-operatively) was assessed clinically. RESULTS. Goserelin was associated with resolution of pelvic pain in the six women who obtained relief of pain with oophorectomy. The only woman who did not respond to goserelin also failed to gain relief with surgery. One woman who responded to goserelin declined surgery.

CONCLUSIONS:

Suppression of ovarian function by GnRH analogues may allow differentiation of pelvic pain caused by the residual ovary syndrome from other causes. This would enable selection of cases likely to benefit from surgery, avoiding potentially difficult surgery in women who will gain little or no relief of symptoms with surgery. Only eight cases are reported and a randomised controlled trial would be required to determine the place of GnRH agonists in the treatment of the residual ovary syndrome.

PMID:
8616132
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center